Hubei Biocause Pharmaceutical Co., Ltd. (SHE:000627)

Market Cap	13.54B
Revenue (ttm)	40.70B
Net Income (ttm)	-771.87M
Shares Out	4.94B
EPS (ttm)	-0.15
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	276,847,735
Average Volume	24,023,126
Open	2.740
Previous Close	2.740
Day's Range	2.740 - 2.890
52-Week Range	1.610 - 5.420
Beta	0.81
RSI	16.27
Earnings Date	Aug 29, 2025

About SHE:000627

Hubei Biocause Pharmaceutical Co., Ltd. primarily provides life and motor insurance products in China. It also engages in the pharmaceutical, chemical, and new energy fuel businesses. In addition, the company is involved in the contract research and production of APIs, intermediates, and formulations, including tablets, granules, capsules, etc.; and provision of chemicals comprising dimethyl ether gas and a-chloropropionyl chloride. It exports its products to approximately 85 countries, including the United States, the European Union, and inter...

• Industry: Insurance - Life
• Sector: Financials
• CEO: Wenxia Zhou
• Employees: 1,765
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000627